The latest closing stock price for Regulus Therapeutics as of September 18, 2024 is 1.62.
An investor who bought $1,000 worth of Regulus Therapeutics stock at the IPO in 2012 would have $-997 today, roughly -1 times their original investment - a -38.24% compound annual growth rate over 12 years.
The all-time high Regulus Therapeutics stock closing price was 2649.60 on November 07, 2014.
The Regulus Therapeutics 52-week high stock price is 3.79, which is 134% above the current share price.
The Regulus Therapeutics 52-week low stock price is 1.08, which is 33.3% below the current share price.
The average Regulus Therapeutics stock price for the last 52 weeks is 1.73.
An investor who bought $1,000 worth of Regulus Therapeutics stock at the IPO in 2012 would have $-997 today, roughly -1 times their original investment - a -38.24% compound annual growth rate over 12 years.
The all-time high Regulus Therapeutics stock closing price was 2649.60 on November 07, 2014.
The Regulus Therapeutics 52-week high stock price is 3.79, which is 134% above the current share price.
The Regulus Therapeutics 52-week low stock price is 1.08, which is 33.3% below the current share price.
The average Regulus Therapeutics stock price for the last 52 weeks is 1.73.